about us

Improving Drug Efficacy

Rxight (pronounced “right”) is a pharmacogenetic program - designed by our founders, Matthew Rutledge and Denis Grizelj - that helps providers make a more informed prescribing decision to help their patients get the right medication at the right dose, the first time, based on their genetic profile. Importantly, Rxight also helps patients avoid medications that are ineffective or could cause dangerous side effects or adverse drug reactions. The Rxight team was invited by the White House to present this novel Precision Medicine program to the Office of Science and Technology Policy.

Read more information about our founders here: Denis Grizelj & Matthew Rutledge

As a high complexity Clinical Laboratory Improvements Amendments (CLIA) certified lab, MD Labs adheres to best practices to provide accurate and comprehensive pharmacogenetic results.